Procter & Gamble (NYSE:PG) Price Target Raised to $191.00

Procter & Gamble (NYSE:PG) had its price objective lifted by Morgan Stanley from $174.00 to $191.00 in a research report sent to investors on Monday morning, Benzinga reports. Morgan Stanley currently has an overweight rating on the stock.

A number of other equities analysts have also weighed in on PG. TD Cowen initiated coverage on shares of Procter & Gamble in a research report on Tuesday, July 23rd. They set a “buy” rating and a $189.00 price target on the stock. StockNews.com lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Procter & Gamble from $171.00 to $176.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Barclays lowered shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target on the stock. in a research report on Monday, September 30th. Finally, Jefferies Financial Group lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating and decreased their target price for the company from $182.00 to $175.00 in a report on Wednesday, July 24th. Nine investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $177.00.

Procter & Gamble Stock Down 0.1 %

Shares of NYSE PG opened at $169.58 on Monday. The company’s 50-day simple moving average is $171.88 and its 200-day simple moving average is $167.45. Procter & Gamble has a 52-week low of $142.50 and a 52-week high of $177.94. The firm has a market cap of $400.23 billion, a price-to-earnings ratio of 27.71, a price-to-earnings-growth ratio of 3.72 and a beta of 0.41. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The firm had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. Procter & Gamble’s quarterly revenue was down .6% on a year-over-year basis. During the same period in the previous year, the business posted $1.83 earnings per share. Equities analysts predict that Procter & Gamble will post 6.98 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be paid a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a yield of 2.37%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s payout ratio is currently 65.69%.

Insider Buying and Selling

In related news, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the sale, the insider now directly owns 11,537 shares of the company’s stock, valued at $1,902,451.30. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Procter & Gamble news, CEO Jon R. Moeller sold 72,174 shares of the stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $171.01, for a total value of $12,342,475.74. Following the sale, the chief executive officer now directly owns 263,158 shares of the company’s stock, valued at approximately $45,002,649.58. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the completion of the sale, the insider now directly owns 11,537 shares in the company, valued at approximately $1,902,451.30. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 385,186 shares of company stock valued at $65,479,358 in the last ninety days. Company insiders own 0.17% of the company’s stock.

Institutional Investors Weigh In On Procter & Gamble

Large investors have recently modified their holdings of the company. Lloyd Advisory Services LLC. grew its position in shares of Procter & Gamble by 493.1% in the 1st quarter. Lloyd Advisory Services LLC. now owns 10,990 shares of the company’s stock valued at $1,783,000 after buying an additional 9,137 shares during the last quarter. Traynor Capital Management Inc. grew its position in shares of Procter & Gamble by 15.9% in the 1st quarter. Traynor Capital Management Inc. now owns 6,046 shares of the company’s stock valued at $981,000 after buying an additional 830 shares during the last quarter. Southland Equity Partners LLC grew its position in shares of Procter & Gamble by 12.5% in the 1st quarter. Southland Equity Partners LLC now owns 36,858 shares of the company’s stock valued at $5,980,000 after buying an additional 4,087 shares during the last quarter. Global Assets Advisory LLC purchased a new position in shares of Procter & Gamble in the 1st quarter valued at $27,383,000. Finally, Financial Synergies Wealth Advisors Inc. grew its position in shares of Procter & Gamble by 124.6% in the 1st quarter. Financial Synergies Wealth Advisors Inc. now owns 878 shares of the company’s stock valued at $142,000 after buying an additional 487 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.